Zdrowie i gospodarka · 05/11/1998

FDA Proposes Electronic Reporting of Postmarketing Adverse Drug Reactions

The Food and Drug Administration (FDA) is seeking public comment on a proposed rule that would require pharmaceutical companies to electronically submit postmarketing safety reports, aiming to harmonize global reporting and enhance public health protection.